CHEK1 and neoplasm: Suppression of CHK1 in cancer cells impairs the DDR and DNA repair, which eventually potentiates the cell-killing effect of chemotherapeutic drugs [26], enhances the anti-tumor effect of PD-L1 blockade, and augments cytotoxic T-cell infiltration in vivo [45].